Several key mutations associated with different tumorigenesis pathways and survival, such as BRAF V600E and KRAS, are significantly more common in right-sided colon cancers, while the mutations of APC and TP53 are enriched in left-sided colon cancers (4, 27–31). Here, BRAF is linked to malignant colon neoplasm.